| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/11/1994 | CA2148685A1 Truncated insulin-like growth factor binding proteins having mitogenic activity |
| 05/11/1994 | CA2148622A1 Recombinant method and host for manufacture of xylitol |
| 05/11/1994 | CA2148483A1 Methods and procedures for preparing red blood fractions |
| 05/11/1994 | CA2148451A1 Plants with reduced susceptibility to plant-parasitic nematodes |
| 05/11/1994 | CA2148379A1 A liquid chromatographic system |
| 05/11/1994 | CA2148368A1 Tnf-.alpha. ribozymes and degradation resistant mrna derivatives linked to tnf-.alpha. ribozymes |
| 05/11/1994 | CA2148358A1 Plant fatty acid synthases |
| 05/11/1994 | CA2148350A1 Methods of detecting micrometastasis of prostate cancer |
| 05/11/1994 | CA2148274A1 Protein p53 fragments and their uses in detecting and following-up pathological conditions |
| 05/11/1994 | CA2148258A1 Transcription factor dp-1 |
| 05/11/1994 | CA2148244A1 Angiogenesis inhibitory antibodies |
| 05/11/1994 | CA2148119A1 Interferon tau compositions and methods of use |
| 05/11/1994 | CA2147756A1 Peptides and vaccines derived from nematode tubulin |
| 05/11/1994 | CA2147754A1 Compositions and methods for modifying the regulatory activity of tgf- .beta. |
| 05/11/1994 | CA2147617A1 Medium-chain thioesterases in plants |
| 05/11/1994 | CA2147605A1 Small molecule inhibition of rna/ligand binding |
| 05/11/1994 | CA2147598A1 Op-3-induced morphogenesis |
| 05/11/1994 | CA2147496A1 Assay for inhibitors of farnesyl-protein transferase |
| 05/11/1994 | CA2147252A1 Rna packaging system |
| 05/11/1994 | CA2146926A1 Conjugate vaccine against group b streptococcus |
| 05/11/1994 | CA2146559A1 Methods of preparing soluble, oligomeric proteins |
| 05/11/1994 | CA2145546A1 Somatotropin modifications |
| 05/11/1994 | CA2143489A1 Transformed endothelial cells |
| 05/11/1994 | CA2127283A1 Urease-based vaccine against helicobacter infection |
| 05/11/1994 | CA2126967A1 Novel antibody construct |
| 05/11/1994 | CA2120131A1 Expression and purification of cloned human alpha-fetoprotein |
| 05/11/1994 | CA2088938A1 Mycoplasma probes |
| 05/10/1994 | USRE34606 Modified enzymes and methods for making same |
| 05/10/1994 | US5310893 Oligonucleotide probe |
| 05/10/1994 | US5310883 Stabilized versions of glu-3,5-basic FGF having eliminated disulfide scrambled forms; wound healing agents; promoters of angiogenesis, neutrotropism and chemotaxis |
| 05/10/1994 | US5310882 Somatotropins with alterations in the α-helix 3 region |
| 05/10/1994 | US5310876 Expression of HIV1 and HIV2 polypeptides and their use |
| 05/10/1994 | US5310678 Genetic engineering, poultry |
| 05/10/1994 | US5310677 Rifampicin resistant xanthan hyperproducing Xanthomonas campestris strain |
| 05/10/1994 | US5310675 Mutated subtilisin; genetic engineering |
| 05/10/1994 | US5310672 Antitumor agents |
| 05/10/1994 | US5310671 Vector for foreign dna and sequence for regulating thegene; vaccines |
| 05/10/1994 | US5310669 Biochemical immobilazion |
| 05/10/1994 | US5310668 Varicella-zoster virus as a live recombinant vaccine |
| 05/10/1994 | US5310667 Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases |
| 05/10/1994 | US5310665 Modifying by substituting a diffferent amino acid from that occuring in at least one position of natural isomerase |
| 05/10/1994 | US5310664 Site specific double stranded DNA endonuclease |
| 05/10/1994 | US5310663 Affinity peptides |
| 05/10/1994 | US5310662 Receptors: their identification, characterization, preparation and use |
| 05/10/1994 | US5310661 Nucleic acid encoding the α chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
| 05/10/1994 | US5310660 Method and a hybrid promoter for controlling exogenous gene transcription |
| 05/10/1994 | US5310659 GL-7ACA acylase |
| 05/10/1994 | US5310654 Method for determining virulence of Yersinia |
| 05/10/1994 | US5310652 Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription |
| 05/06/1994 | CA2102463A1 Protein and gene encoding said protein |
| 05/06/1994 | CA2102256A1 Drug resistance-conferring protein, antibodies reactive therewith and utilities thereof |
| 05/05/1994 | DE4324671A1 Amplifizierbarer Vektor gegen HIV Replikation Amplifiable vector against HIV replication |
| 05/05/1994 | DE4237244A1 Verfahren zur Herstellung hochreiner humaner GAD-1- und GAD-2- Proteine Process for the preparation of highly pure human GAD-1 and GAD-2 proteins |
| 05/05/1994 | DE3348289C2 Pure human tissue plasminogen activator |
| 05/04/1994 | EP0595659A2 Extracellular matrix receptor ligands that modulate leukocyte function |
| 05/04/1994 | EP0595436A2 Porcine respiratory and reproductive disease virus, vaccines and viral DNA |
| 05/04/1994 | EP0595334A2 Mutant AOX2 promoter, vector carrying same, transformant, and production of heterologous protein |
| 05/04/1994 | EP0595241A2 Determination and inhibition of malic enzyme in tumor cells |
| 05/04/1994 | EP0594959A1 A chemiluminescent method for the quantitation of human DNA |
| 05/04/1994 | EP0594881A1 Expression vectors and their application in the construction of HIV-resistant human cells for therapeutic uses |
| 05/04/1994 | EP0594847A1 Dna coding for human fk506-binding protein and expression thereof |
| 05/04/1994 | EP0594843A1 Antibody assay for amylin |
| 05/04/1994 | EP0594776A1 Plasmid replication origin increasing the number of copies of the plasmid containing said origin |
| 05/04/1994 | EP0594771A1 Nucleotide sequences and resistance proteins cycloheximide |
| 05/04/1994 | EP0594764A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 05/04/1994 | EP0594743A1 Continuous cell line and vaccine against avian coccidia |
| 05/04/1994 | EP0594732A1 Humanized antibody against cd18 |
| 05/04/1994 | EP0594710A1 Tyrosine kinase |
| 05/04/1994 | EP0594678A1 Production of polyalkanoate |
| 05/04/1994 | EP0594631A1 Bordetella bronchiseptica outer membrane antigen |
| 05/04/1994 | EP0594610A1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE |
| 05/04/1994 | EP0594584A1 Nucleic acid enzymes for cleaving dna |
| 05/04/1994 | EP0594576A1 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products |
| 05/04/1994 | EP0516655B1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine |
| 05/04/1994 | EP0514413B1 Immunologically active peptides or polypeptides from the parvovirus b19 |
| 05/04/1994 | EP0439601B1 Composition containing a b epitope of the envelope glycoprotein of a retrovirus and a t epitope of a distinct protein from this virus |
| 05/04/1994 | EP0413695B1 Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3. |
| 05/04/1994 | EP0402450B1 Production of fermented food products |
| 05/04/1994 | EP0274527B1 Use of bacterial luciferase structural genes for cloning and monitoring gene expression in microorganisms and for tagging and identification of genetically engineered organisms |
| 05/04/1994 | EP0229046B1 Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique |
| 05/04/1994 | CN1086264A Method for preparing antigenic protein capable of testing C-type hepatitis by using colibacillus |
| 05/04/1994 | CN1086262A New DNA sequences |
| 05/04/1994 | CN1086261A Synthetic tRNAs |
| 05/04/1994 | CN1086143A Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 05/04/1994 | CN1086142A Vaccines |
| 05/03/1994 | US5308770 Cloning and overexpression of glucose-6-phosphate dehydrogenase from Leuconostoc dextranicus |
| 05/03/1994 | US5308765 Esterase genes, esterase, recombinant plasmids and transformants containing the recombinant plasmid and methods of producing optically acitve carboxylic acids and their enantiomeric esters using said transformants |
| 05/03/1994 | US5308760 Crystal proteins of Bacillus thuringiensis, genes encoding them, and host expressing them |
| 05/03/1994 | US5308750 Binders for hepatitis C virus and hybridomas and antigens |
| 05/03/1994 | CA1329308C Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
| 05/03/1994 | CA1329162C Process for inducing cytochrome p-450 enzymes in streptomyces bacteria and determining the mutagenicity of chemicals |
| 05/03/1994 | CA1329157C Method for activating gene technologically produced, heterologous, eucaryotic proteins comprising disulphide bridges after expression in procaryotes |
| 05/03/1994 | CA1329156C Immunoglobulin conjugates |
| 05/01/1994 | CA2109398A1 Extracellular matrix receptor ligands that modulate leukocyte function |
| 04/30/1994 | CA2109481A1 Anti-metastatic vaccine |
| 04/28/1994 | WO1994009160A1 Method of inhibiting replication of hyperproliferative cells |
| 04/28/1994 | WO1994009159A2 Insertion elements and amplifiable nucleic acids |
| 04/28/1994 | WO1994009158A1 Method for selecting nucleic acids on the basis of structure |
| 04/28/1994 | WO1994009155A1 Methods of detecting alzheimer's disease |
| 04/28/1994 | WO1994009148A1 Process for producing major histocompatibility antigen class ii protein and material having the same immobilized thereon |